These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 24743909)

  • 41. Impact of insulin-like growth factor type 1 receptor, epidermal growth factor receptor, and HER2 expressions on outcomes of patients with gastric cancer.
    Matsubara J; Yamada Y; Hirashima Y; Takahari D; Okita NT; Kato K; Hamaguchi T; Shirao K; Shimada Y; Shimoda T
    Clin Cancer Res; 2008 May; 14(10):3022-9. PubMed ID: 18483367
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparative study of tumor angiogenesis and immunohistochemistry for p53, c-ErbB2, c-myc and EGFr as prognostic factors in gastric cancer.
    Sanz-Ortega J; Steinberg SM; Moro E; Saez M; Lopez JA; Sierra E; Sanz-Esponera J; Merino MJ
    Histol Histopathol; 2000 Apr; 15(2):455-62. PubMed ID: 10809364
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Adenocarcinoma in the middle third of the stomach--an evaluation for the prognostic significance of clinicopathological features.
    Sheen-Chen SM; Chou CW; Chen MC; Chen FC; Chen YS; Chen JJ
    Hepatogastroenterology; 1997; 44(17):1488-94. PubMed ID: 9356878
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Robust vascular invasion concurrent with intense EGFR immunostaining can predict recurrence in patients with stage IB node-negative gastric cancer.
    Araki I; Washio M; Yamashita K; Hosoda K; Ema A; Mieno H; Moriya H; Katada N; Kikuchi S; Watanabe M
    Surg Today; 2018 May; 48(5):478-485. PubMed ID: 29256147
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Clinical significance of the human epidermal growth factor receptor 2( HER2) in patients with recurrent gastric cancer who received S-1 adjuvant chemotherapy].
    Aoyama T; Hayashi T; Fujikawa H; Ogata T; Cho H; Wada H; Kitani Y; Yukawa N; Oshima T; Rino Y; Ozawa Y; Masuda M; Yoshikawa T
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):1647-9. PubMed ID: 24393876
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Relationship between expression of IGFBP7 and clinicopathological variables in gastric cancer.
    Sato Y; Inokuchi M; Takagi Y; Otsuki S; Fujimori Y; Yanaka Y; Kobayashi K; Higuchi K; Kojima K; Kawano T
    J Clin Pathol; 2015 Oct; 68(10):795-801. PubMed ID: 26043748
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Multiple sporadic gastrointestinal stromal tumors concomitant with ampullary adenocarcinoma: a case report with KIT and PDGFRA mutational analysis and miR-221/222 expression profile.
    Blandamura S; Alessandrini L; Bertorelle R; Simonato F; Guzzardo V; Valentini E; Angriman I; Fassina A
    Pathol Res Pract; 2014 Jun; 210(6):392-6. PubMed ID: 24674454
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Expressions and clinical significances of c-MET, p-MET and E2f-1 in human gastric carcinoma.
    Wu JG; Yu JW; Wu HB; Zheng LH; Ni XC; Li XQ; Du GY; Jiang BJ
    BMC Res Notes; 2014 Jan; 7():6. PubMed ID: 24393368
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Usefulness and limitation of multiple endoscopic biopsy sampling for epidermal growth factor receptor and c-erbB-2 testing in patients with gastric adenocarcinoma.
    Kimura M; Tsuda H; Morita D; Shinto E; Tanimoto T; Ichikura T; Mochizuki H; Matsubara O
    Jpn J Clin Oncol; 2005 Jun; 35(6):324-31. PubMed ID: 15928192
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Expression of KIT and PDGFR is associated with a good prognosis in neuroblastoma.
    Shimada A; Hirato J; Kuroiwa M; Kikuchi A; Hanada R; Wakai K; Hayashi Y
    Pediatr Blood Cancer; 2008 Feb; 50(2):213-7. PubMed ID: 17941064
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinicopathologic features and treatment outcomes of patients with human epidermal growth factor receptor 2-positive adenocarcinoma of the esophagus and gastroesophageal junction.
    Phillips BE; Tubbs RR; Rice TW; Rybicki LA; Plesec T; Rodriguez CP; Videtic GM; Saxton JP; Ives DI; Adelstein DJ
    Dis Esophagus; 2013 Apr; 26(3):299-304. PubMed ID: 22676551
    [TBL] [Abstract][Full Text] [Related]  

  • 52. erbB-2 expression in well-differentiated adenocarcinoma of the stomach predicts shorter survival after curative resection.
    Motojima K; Furui J; Kohara N; Izawa K; Kanematsu T; Shiku H
    Surgery; 1994 Mar; 115(3):349-54. PubMed ID: 7907434
    [TBL] [Abstract][Full Text] [Related]  

  • 53. STAT3 expression in gastric cancer indicates a poor prognosis.
    Kim DY; Cha ST; Ahn DH; Kang HY; Kwon CI; Ko KH; Hwang SG; Park PW; Rim KS; Hong SP
    J Gastroenterol Hepatol; 2009 Apr; 24(4):646-51. PubMed ID: 19175826
    [TBL] [Abstract][Full Text] [Related]  

  • 54. AKR1B10, a good prognostic indicator in gastric cancer.
    Yao HB; Xu Y; Chen LG; Guan TP; Ma YY; He XJ; Xia YJ; Tao HQ; Shao QS
    Eur J Surg Oncol; 2014 Mar; 40(3):318-24. PubMed ID: 24406159
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Analysis of potential receptor tyrosine kinase targets in intimal and mural sarcomas.
    Tamborini E; Casieri P; Miselli F; Orsenigo M; Negri T; Piacenza C; Stacchiotti S; Gronchi A; Pastorino U; Pierotti MA; Pilotti S
    J Pathol; 2007 Jun; 212(2):227-35. PubMed ID: 17471466
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Expression of the tyrosine kinase activity growth factor receptors (EGFR, ERB B2, ERB B3) in colorectal adenocarcinomas and adenomas.
    Porebska I; Harlozińska A; Bojarowski T
    Tumour Biol; 2000; 21(2):105-15. PubMed ID: 10686540
    [TBL] [Abstract][Full Text] [Related]  

  • 57. HER2 Expression Status and Prognostic, Diagnostic, and Demographic Properties of Patients with Gastric Cancer: a Single Center Cohort Study from Iran.
    Feizy A; Karami A; Eghdamzamiri R; Moghimi M; Taheri H; Mousavinasab N
    Asian Pac J Cancer Prev; 2018 Jun; 19(6):1721-1725. PubMed ID: 29938472
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immunohistochemical detection of p53 protein, c-erbB-2 protein, epidermal growth factor receptor protein and proliferating cell nuclear antigen in gastric carcinoma.
    Jang WI; Yang WI; Lee CI; Kim HS; Song KS; Cho MY; Park JK; Shim YH
    J Korean Med Sci; 1993 Aug; 8(4):293-304. PubMed ID: 7911025
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical significance of the epidermal growth factor receptor and HER2 receptor in resectable gastric cancer.
    García I; Vizoso F; Martín A; Sanz L; Abdel-Lah O; Raigoso P; García-Muñiz JL
    Ann Surg Oncol; 2003 Apr; 10(3):234-41. PubMed ID: 12679307
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Potential prognostic significance of p185(HER2) overexpression with loss of PTEN expression in gastric carcinomas.
    Im SA; Lee KE; Nam E; Kim DY; Lee JH; Han HS; Seoh JY; Park HY; Cho MS; Han WS; Lee SN
    Tumori; 2005; 91(6):513-21. PubMed ID: 16457151
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.